This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Dermatology  • Dermatologic Disorders  • Quality of Care  • Evidence-Based Medicine  • Randomized Controlled Trial  • Dermatologic Disorders, Other  • Dermatology, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Arch Dermatol. 2001;137:1635-1636.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Systematic Review of Treatments of Atopic Eczema
Hoare C, Li Wan Po A, Williams H
Health Technol Assess
2000;4:1:1-191

The following synopsis is the "executive summary" of the systematic review in the authors' own words:

Atopic eczema is the commonest inflammatory skin disease of childhood, affecting 15-20% of children in the UK [United Kingdom] at any one time. Adults make up about one-third of all community cases. Moderate-to-severe atopic eczema can have a profound effect on the quality of life for both sufferers and their families. In addition to the effects of intractable itching, skin damage, soreness, sleep loss and the social stigma of a visible skin disease, other factors such as frequent visits to doctors, special clothing and the need to constantly apply messy topical applications all add to the burden of disease. The cause of atopic eczema is unknown, though a genetic pre-disposition and a combination of allergic . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter